Today: 19 May 2026
Anglo American share price ends near 1-year high as metal rally sets up the week ahead
25 January 2026
1 min read

Anglo American share price ends near 1-year high as metal rally sets up the week ahead

London, Jan 25, 2026, 08:25 GMT — The market has closed.

  • On Friday, Anglo American shares ended 1.08% higher, closing at 3,378 pence.
  • Anglo American plans to release its Q4 2025 production report on Feb. 5, followed by the full-year 2025 results on Feb. 20.
  • Deal chatter persists following Anglo’s $53 billion merger with Teck Resources, with copper prices continuing to dominate the sector’s attention.

Anglo American (AAL.L) shares approach Monday’s London open close to recent peaks, having closed Friday at 3,378 pence, marking a 1.1% gain for the day.

This matters now since the stock’s been moving more like a macro play: metals prices, merger news, and risk appetite are driving the action as investors hold out for the company’s upcoming operational updates.

The shares climbed roughly 4% over the last week, bouncing between a 4.9% surge on Jan. 21 and a 1.7% dip the following day, then closing up on Friday. The stock reached an intraday high of 3,451 pence on Jan. 22.

By Friday’s close, Anglo hovered just below the peak of its 52-week range, recorded by Investing.com as 1,641.5 to 3,451.0 pence.

Much of the momentum stems from the broader mining sector. Spot platinum surged to a record $2,684.43 an ounce on Friday, marking a 27% gain year-to-date, Reuters reported. Prices climbed on the back of the European Union’s revised stance on the 2035 combustion-engine ban and ongoing supply constraints.

Copper stands out as the main draw in Anglo’s equity narrative. The miner, diversified across copper, premium iron ore, and crop nutrients along with other holdings, has been actively reshaping its portfolio.

Investors are watching the Anglo-Teck deal closely. EU regulators must rule by Feb. 10 under a streamlined antitrust review, with a separate decision on the bloc’s Foreign Subsidies Regulation due by Feb. 3, per a European Commission filing Reuters cited.

The setup remains fragile. A drop in metals prices could slam miners fast, while any unexpected hiccup in production or cost could rattle a stock that’s already baked in plenty of positive news.

Anglo American’s Q4 production figures drop on Feb. 5, setting the stage before the full-year results arrive on Feb. 20.

Stock Market Today

  • Top 5 Blue-Chip Stocks to Boost Portfolio Returns in 2026
    May 19, 2026, 9:58 AM EDT. The Dow Jones Industrial Average briefly surpassed 50,000 in May, highlighting positive momentum supported by its position above key moving averages. Analysts recommend five blue-chip stocks with strong Zacks Rank #2 (Buy) ratings to enhance portfolios in 2026: Cisco Systems (CSCO), Salesforce (CRM), Apple (AAPL), Visa (V), and Chevron (CVX). Cisco benefits from robust AI infrastructure demand and restructuring to focus on growth areas. Salesforce is expanding generative AI offerings through Einstein GPT and strategic investments. These stocks are favored for potential revenue and earnings growth amid evolving technological and economic trends.

Latest articles

Bakkt Up Early After Director Buys $4.85M in Shares

Bakkt Up Early After Director Buys $4.85M in Shares

19 May 2026
Bakkt shares jumped 14.2% to $9.96 in pre-market trading Tuesday after a filing showed director Michael Alfred’s vehicle bought $4.85 million in stock. SEC documents said Alfred acquired 585,000 shares last week via Alpine Fox LP. CEO Akshay Naheta exercised options for 33,557 shares at $10 each. Bakkt recently reported Q1 revenue of $243.6 million, down sharply from a year earlier.
Relay Therapeutics Shares Rise In Pre-Market Ahead Of Key Drug Update

Relay Therapeutics Shares Rise In Pre-Market Ahead Of Key Drug Update

19 May 2026
Relay Therapeutics shares jumped 11.3% to $13.47 in premarket trading Tuesday after reporting a 60% volumetric response rate in 20 evaluable patients from its Phase 2 trial of zovegalisib for vascular anomalies. The company said 95% of patients saw some lesion reduction at 12 weeks. No patients discontinued due to adverse events. The regular Nasdaq session was set to open at 9:30 a.m. ET.

Popular

Ondas Shares Drop Following $199 Million AI Defense Deal, Traders Eye Next Steps

Ondas Shares Drop Following $199 Million AI Defense Deal, Traders Eye Next Steps

18 May 2026
Ondas Inc. shares dropped about 10% to $9.555 in midday Nasdaq trading Monday after announcing a $199 million all-stock acquisition of Israeli defense software firm Omnisys and filing for potential resale of over 2.2 million shares tied to a previous deal. Trading volume topped 48 million shares. The Omnisys deal is expected to close in Q2, pending approvals and retention of key staff.
Compass Group share price hits 52-week low; investors eye Feb. 5 update and dividend date
Previous Story

Compass Group share price hits 52-week low; investors eye Feb. 5 update and dividend date

Vallourec’s Delphy hydrogen storage lands Hyvolution award nod as Paris show nears
Next Story

Vallourec’s Delphy hydrogen storage lands Hyvolution award nod as Paris show nears

Go toTop